Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: INO

Inovio Pharmaceuticals, Inc.

Healthcare | Biotechnology
$1.06 +0.00 (+0.00%) as of 2026-07-14 14:23 UTC
Market Cap$90M
Volume2.51M
EPS (TTM)$-1.81

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is a $90M biotechnology company trading at $1.06. Figures from SEC EDGAR and market feeds; updated 2026-07-14 14:23 UTC.

52-Week Range
Low $1.06High $1.06
Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.
Key facts
Quote
Price$1.06
Change (1D)+0.00 (+0.00%)
Market cap$90M
Volume2.51M shares
52-week range$1.06 – $1.06
Valuation
EPS (TTM)$-1.81
Price/book3.74×
Returns
52-week return+0.0%
Revenue, margins & earnings
FY2021: net loss $304M on revenue $2M$2MFY2021FY2022: net loss $280M on revenue $10M$10MFY2022FY2023: net loss $135M on revenue $832,010$832,010FY2023FY2024: net loss $107M on revenue $217,756$217,756FY2024FY2025: net loss $85M on revenue $65,343$65,343FY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →
SEC Filings SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-05-21
  • 2026-05-21YARNO WENDY LA41,800—
  • 2026-05-21YARNO WENDY LA34,200—
  • 2026-05-21Shepard JayA41,800—
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
Source: SEC EDGAR · As of 2026-Q1
  • FMR LLC9,339,573$16.25M-5.2%
  • JANUS HENDERSON GROUP PLC3,308,406$5.77M0.0%
  • VANGUARD GROUP INC3,315,580$5.77M+22.2%
View QoQ ownership changes →
Company news View all →
Questions this page answers

What does Inovio Pharmaceuticals, Inc. do?

Inovio Pharmaceuticals, Inc. is a biotechnology company, listed on NASDAQ as INO.

What is INO's valuation?

INO trades at $1.06, as of 2026-07-14.

When did INO last file with the SEC?

Inovio Pharmaceuticals, Inc.'s most recent SEC filing on record is a DEF 14A filed 2026-04-07. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-14 14:23 UTC. This page is also available as JSON at /api/data?ticker=INO and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for INO and 3,500+ tickers.

Create a free account — keep INO
For your agent
GET /api/data?ticker=INO

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt